Replies to post #22627 on Arena Pharmaceuticals, Inc. (ARNA)

[operating_line]

Agreed that a run up looks possible very soon. The consensus PT has already been about 65 for some time and this should increase when clarification on the low double digit royalties from the latest deal are clarified to analysts.

Interesting to see Takeda pressing ahead with the expensive acquisition of Shire

https://www.fiercepharma.com/pharma/former-takeda-chairman-privately-opposes-shire-buyout-ft

but trying to sell off the Shire treatment for inflammatory bowel disease due to its previous acquisition:

https://pharmaphorum.com/news/takeda-proposes-selling-shires-ibd-treatment-after-merger/

The valuation of that sale could be a catalyst with respect to Etrasimod.